Side-by-side IPO readiness, funding history, and valuation comparison. Data sourced by TechStackIPO.
Scores, valuations, and signals for Databricks, Ginkgo Bioworks, and 370+ companies. 5-min read every Tuesday.
Databricks is the world's most valuable data and AI platform — $134B valuation, $4.2B raised. Widely expected to IPO. Track readiness score and timeline.
| Industry | Enterprise Software |
| Stage | Pre-IPO |
| IPO Status | Private |
| Valuation | $134B |
| Total Funding | $4.5B |
| Headquarters | San Francisco, CA |
Synthetic biology platform programming cells for agriculture, pharmaceuticals, and materials.
| Industry | Biotechnology |
| Stage | Public |
| IPO Status | Public |
| Valuation | $800M |
| Total Funding | $1.6B |
| Headquarters | Boston, MA |
Databricks is valued at $134B. Ginkgo Bioworks is valued at $800M. Both valuations are based on the most recent private funding rounds tracked by TechStackIPO.
Databricks has raised $4.5B. Ginkgo Bioworks has raised $1.6B.
Databricks is currently private. Ginkgo Bioworks is currently already public. Track both on TechStackIPO for S-1 filings and IPO announcements.
Databricks operates in Enterprise Software, while Ginkgo Bioworks operates in Biotechnology.
Databricks is a Enterprise Software company valued at $134B with $4.5B raised. Ginkgo Bioworks is a Biotechnology company valued at $800M with $1.6B raised. See TechStackIPO's full side-by-side comparison for IPO readiness scores, funding timelines, and investor data.
Accredited investors can access pre-IPO shares in Databricks and Ginkgo Bioworks through secondary market platforms, pre-IPO funds, and broker-dealer platforms that facilitate private company transactions. TechStackIPO's marketplace section tracks available access options for both companies. Pre-IPO investments carry higher risk and limited liquidity.